Know Labs, INC 10-Q quarterly reports

USBC, Inc. disclosed significant net losses and a decrease in digital asset holdings for the second quarter of 2026, while continuing development of its tokenized deposit program.

USBC, Inc. reported a net loss of $25.6 million for Q1 2026, significantly impacted by digital asset valuation changes and increased operating expenses related to its tokenized deposit program development.

Know Labs, Inc. reports significant losses and a working capital deficit, raising substantial doubt about its ability to continue as a going concern, despite efforts to secure new capital and reduce operating expenses.

Know Labs reports a net loss of $3.58 million for Q2 2025 and expresses substantial doubt about its ability to continue as a going concern.

Know Labs, Inc. reports a net loss for Q1 2025 while advancing its non-invasive diagnostic technology and launching a technology licensing program.

Know Labs, Inc. released its Q3 2024 financial results, highlighting ongoing development of its non-invasive glucose monitoring technology and recent capital raising activities.

Know Labs, Inc. released its first quarter 2024 financial results, showcasing advancements in its non-invasive glucose monitoring technology and ongoing efforts to secure FDA clearance.

Know Labs, Inc. reported its financial results for the quarter ended December 31, 2023, highlighting ongoing development of its non-invasive glucose monitoring technology and a reduction in operating expenses.